Immunotherapy for #TCellMalignancies raises unique challenges-from antigen overlap to CAR‑T fratricide. This Special Collection brings together translational and early clinical insights addressing these barriers.
Submissions open until 29 Jan 2027
https://t.co/XbDcT9hIdC
Navigating the future of nano‐pesticides: A perspective on design, efficacy, mechanisms, and environmental stewardship
🌱Nano-pesticides are reshaping crop protection toward sustainable agriculture.
https://t.co/zeT5XEpC8r
Two stable gut microbiome guilds predict liver tumor class and treatment responses
⚙️ Functionally opposing microbial guilds highlight an ecological basis for tumor progression and clinical outcomes. #Hepatocellular@WileyHealth
https://t.co/QVa6EJm3wO
Real‑world, 8‑year multicancer study of lenvatinib shows manageable long‑term use across DTC, AdCC, HCC & EC. Notably, BMI declined during treatment (p=0.045), highlighting the need for closer monitoring in low‑BMI patients.
🔗 https://t.co/hWuTnmAyHU
#Lenvatinib@elenacolomboMD
French consensus published in Ther Adv Med Onc-provide practical, real‑world guidance to prevent and manage hematologic toxicities from PARPis in metastatic PC-an area of growing need.
🔗 Full article: https://t.co/AMRFwbCzfa
#ProstateCancer#mCRPC#PARPInhibitors#Oncology
🚀 317 R scripts for biomedical research, no coding barrier
⏱️ Standardized design saves time
✅ Verified, annotated, reproducible
🧬 Covers #scRNA-seq, spatial #transcriptomics, #ML & more
Developed by @guangchuangyu and @PengL_Robin
🔗https://t.co/7RQbAOmrX2
#Bioinformatics
🚨Lin et al. discuss the critical role of clinical trials in medical advancements, emphasizing their importance in verifying treatment efficacy and ensuring patient safety through rigorous study designs and data collection methods https://t.co/XE8lNgJ0w2 @PengL_Robin#BMCMedicine
🎉 Milestone for #iMetaMed!
We’ve just published our first paper, FastUKB 🚀
iMetaMed advances research in multi-#omics, big data, #AI & precision medicine in #healthcare.
More here: https://t.co/xS7vvLkl6z @PengL_Robin
By capturing data across five spatial hierarchies (global, regional, national, subnational, local), our analysis reveals striking disparities in Covid-19 incidence, prevalence, mortality and disability; providing data to improve pandemic preparedness. https://t.co/jli80M3oUS
🚨 Exciting news! We’re launching iMetaMed, a new sub-journal of the iMeta series @iMetaScience to #medicine, #health, and #biotechnology.
It aims to be a high-quality platform for global researchers and clinicians.
🔗 Learn more: https://t.co/5xqrmqOkFU
@WileyHealth @WileyBiomedical @wileymicrobio
Gut #microbiota in treating #inflammatory digestive diseases: Current challenges and therapeutic opportunities https://t.co/4nU5rK9N3N
#microbiome @wileymicrobio @WileyBiomedical @WileyHealth
This review provides a comprehensive synthesis of the current understanding of mesenchymal stem cell-derived exosomes (MSC-Exos) , underscoring their role as a novel and potent therapeutic strategy against the intricate challenges of age-related diseases. https://t.co/AiUUHsOBiB
This review provides a comprehensive overview of the state-of-the-art in non-viral CAR-NK cell engineering, highlighting its potential to revolutionize cancer treatment.
https://t.co/x2zh9upSNg